跳至主要内容
临床试验/NCT03078088
NCT03078088已完成1 期

Airway Alkalinization and Nasal Colonization

Lakshmi Durairaj1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2017年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Nasal bacterial colonization

研究概览

简要总结

The study will be a randomized, cross-over study of THAM followed by saline or saline followed by THAM in human non-CF and CF subjects to assess nasal colonization

详细描述

16 subjects per group will be randomized to receive study drug or saline followed by a wash out period and cross-over to the other treatment, three times daily for 4 days. Nasal swab will be done at baseline and after both study treatment and saline treatment for assessment of airway colonization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 16 subjects, aged 16-80, clinically stable with no significant changes in health status for 14 days prior to Day 1, written informed consent obtained fom subject.

排除标准

  • Pregnant or lactating
  • Use of any investigational drug and/or participated in any interventional clinical trial within 28 days prior to screening, smoked in the last 6 months.
  • CF subjects:
  • Inclusion Criteria:
  • FEV1% >35%, O2 saturation >90% on room air, clinically stable with no significant changes in health status for 14 days prior to Day 1, written informed consent obtained from subject.
  • Exclusion Criteria:
  • Same as for healthy subjects.

研究组 & 干预措施

saline

Placebo Comparator

normal saline

干预措施: Saline (Drug)

treatment

Experimental

tham

干预措施: Tham (Drug)

结局指标

主要结局

Nasal bacterial colonization

时间窗: Day 5 of placebo or Tham intervention

Culture

次要结局

  • Safety assessment questionnaire(Day 5 of placebo or Tham intervention)

研究者

发起方
Lakshmi Durairaj
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lakshmi Durairaj

Staff Physician

University of Iowa

研究点 (1)

Loading locations...

相似试验